Modelling cerebrovascular pathology and the spread of amyloid beta in Alzheimer’s disease
Alzheimer’s disease is characterised by the accumulation and spread of the amyloid beta protein in the brain. Experiments have revealed that amyloid beta oligomers induce microvascular mural cells to contract, thereby constricting capillaries and increasing resistance to blood flow. Conversely, hypo...
Main Authors: | Ahern, A, Thompson, TB, Oliveri, H, Lorthois, S, Goriely, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Royal Society
2025
|
Similar Items
-
A network aggregation model for amyloid-β dynamics and treatment of Alzheimer’s diseases at the brain scale
by: Brennan, GS, et al.
Published: (2025) -
Alzheimer’s Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?
by: Høilund-Carlsen, Poul F., et al.
Published: (2024) -
Investigation on the mechanism of amyloid beta peptides oligomerization and the process for its inhibition
by: Zhao, Li Na
Published: (2013) -
Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
by: Stockman, CA, et al.
Published: (2024) -
The effect of the amyloid-beta peptide on the fluidity of cell membranes : a study by fluorescence correlation spectroscopy
by: Ng, Justin Wei Qing
Published: (2017)